Bretylium Compounds

Name
Bretylium Compounds
Accession Number
DBCAT001283
Description

Benzylammonium compounds with the formula Br-phenyl-CN+R3 that include BRETYLIUM TOSYLATE.

Drugs
DrugDrug Description
BretyliumA norepinephrine release inhibitor used for the prophylaxis and therapy of ventricular fibrillation, as well as the treatment of life-threatening ventricular arrhythmias.
Drugs & Drug Targets
DrugTargetType
BretyliumSodium/potassium-transporting ATPase subunit alpha-1target